Rockwell Medical, Inc (RMTI)

Etorro trading 970x250
Rockwell Medical, Inc (RMTI) Logo

About Rockwell Medical, Inc

Rockwell Medical, Inc. operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. It is also developing an intravenous formulation of Triferic for use by hemodialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient’s bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. Its target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1994 and is based in Wixom, Michigan. Address: 411 Hackensack Avenue, Hackensack, NJ, United States, 07601

Rockwell Medical, Inc News and around…

Latest news about Rockwell Medical, Inc (RMTI) common stock and company :

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
22 Nov, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, traders! We're getting right into the week with a breakdown of the biggest pre-market stock movers for Monday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
18 Nov, 2021 FinancialContent

Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) stock increased by 78.28% to $37.94 during Thursday's pre-market ...

61 Biggest Movers From Yesterday
18 Nov, 2021 FinancialContent

Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at ...

12 Health Care Stocks Moving In Wednesday's After-Market Session
17 Nov, 2021 FinancialContent

Gainers Rani Therapeutics Hldgs (NASDAQ:RANI) stock rose 7.36% to $35.0 during Wednesday's after-market session. The ...

Mid-Afternoon Market Update: Dow Falls 200 Points; Rockwell Medical Shares Spike Higher
17 Nov, 2021 FinancialContent

Toward the end of trading Wednesday, the Dow traded down 0.58% to 35,930.89 while the NASDAQ fell 0.27% to 15,930.79. The S&P also ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
17 Nov, 2021 FinancialContent

Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) shares moved upwards by 25.83% to $17.68 during Wednesday's regular session. The ...

42 Stocks Moving In Wednesday's Mid-Day Session
17 Nov, 2021 FinancialContent

Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint ...

Why Are Rockwell Medical Shares Surging Wednesday?
17 Nov, 2021 FinancialContent

Rockwell Medical Inc(NASDAQ: RMTI) hasannounced the publication of resultsin the Journal of Bioequivalence & ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
17 Nov, 2021 FinancialContent

Gainers Rockwell Medical (NASDAQ:RMTI) shares rose 47.27% to $0.71 during Wednesday's pre-market session. The ...

The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment
17 Nov, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Atea Announces Termination ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
17 Nov, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

25 Stocks Moving in Wednesday's Pre-Market Session
17 Nov, 2021 FinancialContent

Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & ...

Rockwell Medical Study Demonstrates No Drug-drug Interaction Between Ferric Pyrophosphate Citrate and Unfractionated Heparin
16 Nov, 2021 Yahoo! Finance

Findings confirm results from previous population PK study demonstrating safe and effective anticoagulation along with the delivery of Ferric Pyrophosphate Citrate ironWIXOM, Mich., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced the publication of results in the Journal of Bioequivalence & Bioa

12 Health Care Stocks Moving In Monday's After-Market Session
15 Nov, 2021 FinancialContent

Gainers Kezar Life Sciences (NASDAQ:KZR) shares increased by 29.48% to $10.89 during Monday's after-market session. At the close, ...

Rockwell Medical (RMTI) Reports Q3 Loss, Misses Revenue Estimates
15 Nov, 2021 Yahoo! Finance

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -14.29% and -11.47%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Recap: Rockwell Medical Q3 Earnings
15 Nov, 2021 FinancialContent

Rockwell Medical (NASDAQ:RMTI) reported its Q3 earnings results on Monday, November 15, 2021 at 04:00 PM. Here's what investors ...

Rockwell Medical, Inc. Provides Third Quarter 2021 Financial and Operational Update
15 Nov, 2021 Yahoo! Finance

- Third quarter net sales of $16.0 Million, up 6% sequential quarter-over-quarter and 5% year-over-year - - Company recently submitted Investigational New Drug application with FDA for its proposed clinical trial of FPC as a treatment for iron deficiency anemia in patients receiving home infusion - - Company recently presented Triferic® real world evidence update at ASN Kidney Week 2021; results from pilot observational analysis demonstrate maintenance of hemoglobin and reduction of total IV iro

Earnings Scheduled For November 15, 2021
15 Nov, 2021 FinancialContent

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third ...

Rockwell Medical Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12 Nov, 2021 Yahoo! Finance

WIXOM, Mich., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that a majority of the independent directors serving on the Company’s Board of Directors approved option grants to two new employees to purchase an aggregate of 75,000 shares of the Company’s common stock (the “Inducement Grants”). Th

Earnings Preview For Rockwell Medical
12 Nov, 2021 FinancialContent

Rockwell Medical (NASDAQ:RMTI) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to ...

Rockwell Medical Submits Investigational New Drug Application with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion
11 Nov, 2021 Yahoo! Finance

WIXOM, Mich., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) in support of its proposed Phase 2 clinical trial of Ferric Pyrophosphate Citrate (FPC), designed for the treatment o

Rockwell Medical, Inc. to Report Third Quarter 2021 Financial and Operating Results on November 15, 2021
08 Nov, 2021 Yahoo! Finance

WIXOM, Mich., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it will host a conference call on Monday, November 15 at 4:00 PM ET to discuss its financial results for the three months ended September 30, 2021, and recent operational highlights. To access the conference call, please dial (87

Rockwell Medical Presents Triferic® Real World Evidence Update at ASN Kidney Week 2021
04 Nov, 2021 Yahoo! Finance

-Results from pilot observational analysis demonstrate maintenance of hemoglobin and reduction of total IV iron requirement in adult patients on Triferic receiving chronic hemodialysis- -Findings align with pivotal trials of Triferic and prior Real World Evidence- WIXOM, Mich., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients aro

Will Rockwell Medical (RMTI) Report Negative Q3 Earnings? What You Should Know
01 Nov, 2021 Yahoo! Finance

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
07 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
05 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Rockwell Medical's Return On Capital Employed Overview
04 Oct, 2021 FinancialContent

Benzinga Pro data, Rockwell Medical (NASDAQ:RMTI) reported Q2 sales of $15.14 million. Earnings fell to a loss of $7.82 million, ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
14 Sep, 2021 FinancialContent

Gainers Xeris Pharmaceuticals (NASDAQ:XERS) stock rose 4.96% to $2.75 during Tuesday's after-market session. At the close, Xeris ...

Rockwell Medical, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
09 Sep, 2021 FinancialContent
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
20 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Rockwell Medical, Inc (RMTI) is a NASDAQ Common Stock listed in , ,

970x250